Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Packer M., McMurray J. J. V., Desai A. S., Gong J., Lefkowitz M. P., Rizkala A. R., ...Daha Fazla

CIRCULATION, cilt.131, sa.1, ss.54-61, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 131 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1161/circulationaha.114.013748
  • Dergi Adı: CIRCULATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.54-61
  • Anahtar Kelimeler: heart failure, neprilysin, receptors, angiotensin, LEFT-VENTRICULAR DYSFUNCTION, NATRIURETIC-PEPTIDE, NEUTRAL ENDOPEPTIDASE, CONVERTING ENZYME, MYOCARDIAL-INFARCTION, MILD SYMPTOMS, ADRENOMEDULLIN, MORTALITY, EPLERENONE, METABOLISM
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background-Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients.